OFFICIAL PUBLICATION OF

by its subsidiary APPco

Support for new S3 listing

Chris Brooker 15/09/2023

Pharmacy Guild and other groups voice support for a new Schedule 3 listing for celecoxib The Pharmacy Guild of Australia and other peak health stakeholder groups have supported a decision to create a new Schedule 3 category for the NSAID celecoxib. The March 2023 meeting of the Therapeutic Goods Administration's Advisory Committee on Medicines Scheduling

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Gender pay gap must be addressed

If you want to thrive then pivot to industries that provide high remuneration. Everyone seems to think they deserve more…

Ernie Hanson

Gender pay gap must be addressed

Experienced teachers in WA (goes up each year automatically with experience) get $117,000-$130,000. With 12 weeks off a year. Are…

Big Pharma

Gender pay gap must be addressed

I'd be interested in the number of male vs female consultant pharmacists. This entire career path is now geared towards…

Big Pharma

Locum rates forecast to flatten

Try recruiting any pharmacist at less than $55 per hour. $60 for a full time manager sounds about right.

Melinda Matthews

Support for new S3 listing

Previous Overcoming the language barrier

Next The search for security

Clinical tips: Timing!

Clinical tips: Movement disorders

Clinical tips: Worms, Worms, Worms

Intranasal Midazolam for at home use

MENU

Previous Overcoming the language barrier

Next The search for security

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.